120 related articles for article (PubMed ID: 2066610)
21. Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma.
Fattorossi A; Battaglia A; Ferrandina G; Coronetta F; Legge F; Salutari V; Scambia G
Cancer; 2004 Apr; 100(7):1418-28. PubMed ID: 15042676
[TBL] [Abstract][Full Text] [Related]
22. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
23. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
Niibe Y; Kazumoto T; Toita T; Yamazaki H; Higuchi K; Ii N; Suzuki K; Uno T; Tokumaru S; Takayama M; Sekiguchi K; Matsumoto Y; Michimoto K; Oguchi M; Hayakawa K
Gynecol Oncol; 2006 Nov; 103(2):435-8. PubMed ID: 16677691
[TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
Su YJ; Ren K; Li H; Ren XB; Wang CL
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
[TBL] [Abstract][Full Text] [Related]
25. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients?
Scambia G; Ferrandina G; Distefano M; Fagotti A; Manfredi R; Zannoni GF; Mancuso S
Gynecol Oncol; 2001 Nov; 83(2):319-24. PubMed ID: 11606092
[TBL] [Abstract][Full Text] [Related]
26. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
Obi Y
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):293-302. PubMed ID: 2051981
[TBL] [Abstract][Full Text] [Related]
28. Lymphatic vessel density as a prognostic indicator for patients with stage I cervical carcinoma.
Gao P; Zhou GY; Yin G; Liu Y; Liu ZY; Zhang J; Hao CY
Hum Pathol; 2006 Jun; 37(6):719-25. PubMed ID: 16733213
[TBL] [Abstract][Full Text] [Related]
29. Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis.
Juretzka MM; Jensen KC; Longacre TA; Teng NN; Husain A
Gynecol Oncol; 2004 Apr; 93(1):107-11. PubMed ID: 15047221
[TBL] [Abstract][Full Text] [Related]
30. Profile of immune cells in lymph nodes draining human malignant tumors.
Di Girolamo W; Coronato S; Portiansky E; Laguens G
Medicina (B Aires); 2008; 68(6):423-7. PubMed ID: 19147422
[TBL] [Abstract][Full Text] [Related]
31. Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancer.
Battaglia A; Buzzonetti A; Martinelli E; Fanelli M; Petrillo M; Ferrandina G; Scambia G; Fattorossi A
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1546-53. PubMed ID: 20338481
[TBL] [Abstract][Full Text] [Related]
32. HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
Lee YS; Rhim CC; Lee HN; Lee KH; Park JS; Namkoong SE
Gynecol Oncol; 2007 May; 105(2):351-7. PubMed ID: 17275890
[TBL] [Abstract][Full Text] [Related]
33. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH
Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718
[TBL] [Abstract][Full Text] [Related]
34. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion.
Ryu HS; Chang KH; Yang HW; Kim MS; Kwon HC; Oh KS
Gynecol Oncol; 2000 Mar; 76(3):320-5. PubMed ID: 10684704
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus DNA in tumor-free regional lymph nodes: a potential prognostic marker in cervical carcinoma.
Ikenberg H; Wiegering I; Pfisterer J; Kiechle-Schwarz M; Schmitt B; Sauerbrei W; Pfleiderer A
Cancer J Sci Am; 1996; 2(1):28-34. PubMed ID: 9166495
[TBL] [Abstract][Full Text] [Related]
36. Macrophage activity of regional lymph nodes of cancer patients and its relation to stages of cancer.
Mashiba H; Matsunaga K; Jimi S; Watanabe Y; Kurano A; Saito T; Furusawa M
Invasion Metastasis; 1986; 6(6):367-75. PubMed ID: 3804642
[TBL] [Abstract][Full Text] [Related]
37. [Results of surgical treatment of stage IIb cervix cancer].
Friedberg V; Beck T
Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):782-6. PubMed ID: 2806851
[TBL] [Abstract][Full Text] [Related]
38. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
[TBL] [Abstract][Full Text] [Related]
39. [Functional activity of the regional lymph nodes in breast cancer patients].
Loboda VI; Grinevich IuA
Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
[TBL] [Abstract][Full Text] [Related]
40. Types of reaction in the regional lymph nodes in non-metastatic and minute-metastatic carcinoma of the uterine cervix.
Kozlowski H; Hrabowska M
Arch Geschwulstforsch; 1975; 45(7):658-9. PubMed ID: 58649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
